Abstract
The effects of enalapril on plasma lipoproteins were evaluated in an open study of 12 normolipidemic outpatients with mild-to-moderate essential hypertension (World Health Organization stages I and II). After a two-week washout period, during which placebo was given, the patients received 20 to 40 mg/day of enalapril for 16 weeks. Treatment with enalapril was associated with significant increases in levels of HDL cholesterol (mean, 23%; P2 (mean, 43%; P3 also rose (mean, 14%; P
Original language | English |
---|---|
Pages (from-to) | 635-639 |
Number of pages | 5 |
Journal | Clinical Therapeutics |
Volume | 9 |
Issue number | 6 |
Publication status | Published - 1987 |
ASJC Scopus subject areas
- Pharmacology